Financial reports
10-Q
2016 Q3
Quarterly report
9 Nov 16
10-Q
2016 Q2
Quarterly report
8 Aug 16
10-Q
2016 Q1
Quarterly report
10 May 16
10-K
2015 FY
Annual report
15 Mar 16
10-Q
2015 Q3
Quarterly report
6 Nov 15
10-Q
2015 Q2
Quarterly report
7 Aug 15
10-Q
2015 Q1
Quarterly report
8 May 15
ARS
2014 FY
Annual report to shareholders
14 Apr 15
10-K
2014 FY
Annual report
11 Mar 15
10-Q
2014 Q3
Quarterly report
7 Nov 14
Current reports
8-K/A
Financial Statements and Exhibits
7 Mar 17
8-K
Completion of Acquisition or Disposition of Assets
24 Feb 17
8-K
Departure of Directors or Certain Officers
25 Jan 17
8-K
Derma Sciences Buys MEDIHONEY® Brand From Long-Term Partner
17 Jan 17
8-K
Entry into a Material Definitive Agreement
17 Jan 17
8-K/A
Financial Statements and Exhibits
21 Oct 16
8-K
Derma Sciences Completes the Sale of Its First Aid Products Division
8 Sep 16
8-K
Departure of Directors or Certain Officers
26 Aug 16
8-K
Completion of Acquisition or Disposition of Assets
11 Aug 16
8-K
Derma Sciences to Acquire Biod, Solidify Its Leadership Position In Advanced Wound Care and Regenerative Products
1 Aug 16
Registration and prospectus
15-12B
Securities registration termination
7 Mar 17
25-NSE
Exchange delisting
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
POS AM
Prospectus update (post-effective amendment)
24 Feb 17
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Feb 17
Proxies
DEFA14A
Additional proxy soliciting materials
20 Apr 16
DEF 14A
Definitive proxy
20 Apr 16
DEFA14A
Additional proxy soliciting materials
9 Apr 15
DEF 14A
Definitive proxy
9 Apr 15
DEFA14A
Additional proxy soliciting materials
9 Apr 14
DEF 14A
Definitive proxy
9 Apr 14
PRE 14A
Preliminary proxy
27 Mar 14
DEF 14A
Definitive proxy
12 Apr 13
DEFA14A
Additional proxy soliciting materials
12 Apr 13
PRE 14A
Preliminary proxy
1 Apr 13
Other
CT ORDER
Confidential treatment order
15 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
EFFECT
Notice of effectiveness
7 Mar 17
CT ORDER
Confidential treatment order
28 Oct 16
CT ORDER
Confidential treatment order
3 Apr 14
Ownership
SC 13G/A
Derma Sciences, Inc.
2 Feb 18
SC 13G/A
Derma Sciences, Inc.
10 Mar 17
SC 13D/A
Derma Sciences, Inc.
28 Feb 17
4
SAMUEL E NAVARRO
24 Feb 17
4
STEPHEN T WILLS
24 Feb 17
4
JOHN E YETTER
24 Feb 17
4
SRINI CONJEEVARAM
24 Feb 17
4
Frederic Eigner
24 Feb 17
4
Brett Hewlett
24 Feb 17
4
ROBERT C COLE
24 Feb 17